Bryan Howcroft is the new chief executive and director of Medipharm Labs Corp.
Starting Nov. 15, Howcroft will bring his 20 years of healthcare and manufacturing experience to the Barrie, Ont.-based cannabis extraction company. Before joining Medipharm, Howcroft served as chief operational officer and chief financial officer of Southmedic, a company that provides healthcare products, custom manufacturing and distribution to more than 60 countries.
“As a pharmaceutical company specialized in precision-based cannabinoids, MediPharm Labs was seeking a CEO who could lead the charge on increased sales in the medical and consumer markets,” said Chris Taves, chairman of MediPharm Labs. “Bryan is a tenacious leader who believes in a customer-first approach that will be critical for MediPharm to scale our business, and will bring a healthy level of urgency to pursue the many opportunities that lie ahead.”
“I look forward to bringing to MediPharm my successful scaling revenue and business operations and to building long-term competitive advantage,” said Howcroft. “I look at MediPharm’s current business and future potential and see a company that is differentiated in the industry with so much more value than what is attributed to it today. I am excited about the opportunity to re-invigorate investor confidence in MediPharm to support our future growth.”